A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT06176768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3972406 in Adults With Moderate-to-Severe Plaque Psoriasis
Study identification
- NCT ID
- NCT06176768
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Interventions
- LY3972406 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2023
- Primary completion
- Mar 31, 2025
- Completion
- May 5, 2025
- Last update posted
- Oct 14, 2025
2023 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Driven Research | Coral Gables | Florida | 33134 | — |
| Conquest Research | Winter Park | Florida | 32789 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Schweiger Dermatology Group | Hackensack | New Jersey | 07601 | — |
| Metropolitan Dermatology - Clark | Kenilworth | New Jersey | 07033 | — |
| Accellacare - Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| Remington-Davis, Inc | Columbus | Ohio | 43215 | — |
| DermDox Centers for Dermatology | Camp Hill | Pennsylvania | 17011 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Austin Institute for Clinical Research | Houston | Texas | 77056 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06176768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2025 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06176768 live on ClinicalTrials.gov.